CT
Simple answer, can't put product in hospitals until regulatory approval. You can't simply test drugs that don't have FDA just because you own a hospital, same with devices and regulatory approval in Taiwan.
As I said at this stage, they are not enough of a threat to Baxter's and J&J types bottom line. If they can show they have secured Taiwan and Brazil, can navigate the regulatory approval and commence sales, they then pose a real threat or moving into China and South America and will start to make enough noise for a Baxter or J&J to move on them. The major didnt request and test product for fun. The major is likely using Brazil as a form of product validation and DD.
And CT as for reasoning behind Taiwan and Brazil, they are mainly run by family offices as opposed to being dominated by majors. The J&J's types have less of a presence and therefore less barrier to entry.
The device is cheaper, safer, more efficient and when you factor in nurse time and flushing events, saves the hospitals several times it cost - we have been given these numbers. This sort of thing will only be overlooked by majors for so long, the tipping point will be when it becomes a threat to their market share. Brazil and Taiwan start to make that case
Add to My Watchlist
What is My Watchlist?